The development of cancer imaging with radiolabeled antibodies, or radioimmunodetection (RAID), has spanned at least 2 decades, if we begin dating this from the use of antibodies made against human tumor-associated antigens, such as oncofetal
David M. Goldenberg, SCD, MD
Advertisement
Articles by David M. Goldenberg, SCD, MD
Advertisement
Latest Updated Articles
- Commentary (Goldenberg): Diagnostic Use of Radiolabeled Antibodies for Cancer
Published: July 1st 1995 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
2
Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study
3
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
4
Disitamab Vedotin/Toripalimab Combo Prolongs Survival in Frontline HER2+ Urothelial Cancer
5
